-
公开(公告)号:DE602004003256T2
公开(公告)日:2007-05-03
申请号:DE602004003256
申请日:2004-06-18
Applicant: CELLTECH R&D LTD
Inventor: OWEN DAVID ALAN , WATSON ROBERT JOHN , ALLEN DANIEL REES , SHARPE ANDREW , DYKE HAZEL JOAN
IPC: C07D211/96 , A61K31/451 , A61P37/00
-
公开(公告)号:AT345328T
公开(公告)日:2006-12-15
申请号:AT04742999
申请日:2004-06-18
Applicant: CELLTECH R&D LTD
Inventor: OWEN DAVID ALAN , WATSON ROBERT JOHN , ALLEN DANIEL REES , SHARPE ANDREW , DYKE HAZEL JOAN
IPC: A61P37/00 , C07D211/96 , A61K31/451
-
公开(公告)号:CA2526880A1
公开(公告)日:2004-11-04
申请号:CA2526880
申请日:2004-04-08
Applicant: CELLTECH R&D LTD
Inventor: MEISSNER JOHANNES WILHELM GEOR , WATSON ROBERT JOHN , OWEN DAVID ALAN
IPC: C07D211/58 , A61K31/452 , A61P37/02 , A61P37/08 , C07D409/12
Abstract: Compounds of formula (1) wherein,m,n,R1,R2,Ra,ALK3, E and Y are as defined i n the claims, being potent and selective inhibitors of chemokine binding to th e CXCR3 receptor, are accordingly of use in the treatment and/or prevention of conditions involving inappropriate T-cell trafficking, including inflammator y, autoimmune and immurforegulatory disorders such as rheumatoid arthritis.
-
公开(公告)号:CA2473089A1
公开(公告)日:2003-08-28
申请号:CA2473089
申请日:2003-02-19
Applicant: CELLTECH R&D LTD
IPC: A61K31/4468 , A61P1/04 , A61P11/06 , A61P17/00 , A61P19/02 , A61P25/00 , A61P27/16 , A61P29/00 , A61P31/12 , A61P33/00 , A61P37/02 , A61P37/06 , C07D211/58 , C07D401/12 , C07D405/12 , C07D409/12 , A61K31/17 , C07C275/28 , A61K31/453 , A61K31/4535 , A61K31/4709
Abstract: Cyclic amino derivatives of formula (1) are described: (1) wherein: m and n, which may be the same or different, is each zero or the integer 1 or 2; AIk3 ~ is a covalent bond or a straight or branched C~1-6 alkylene chain; R1~ and R2~, which may be the same or different, is each a hydrogen atom or a straig ht or branched C~1-6 alkyl group; D is an optionally substituted aromatic or heteroaromatic group; E is an optionally substituted C~7-10 cycloalkyl, C~7- 10 cycloalkenyl or C~7-10 polycycloaliphatic group; and the salts, solvates, hydrates, tautomers or N-oxides thereof. The compounds are potent and selective modulators of the interaction between CXCR3 and its chemokine ligands and are thus of use in medicine, for example in the prevention or treatment of conditions involving inappropriate T-cell trafficking such as certain inflammatory, autoimmune and immunoregulatory disorders as described hereinafter.
-
公开(公告)号:ES2273278T3
公开(公告)日:2007-05-01
申请号:ES04742999
申请日:2004-06-18
Applicant: CELLTECH R&D LTD
Inventor: OWEN DAVID ALAN , WATSON ROBERT JOHN , ALLEN DANIEL REES , SHARPE ANDREW , DYKE HAZEL JOAN
IPC: C07D211/96 , A61K31/451 , A61P37/00
Abstract: Un compuesto de fórmula (1): en la que: Ci es un grupo arilo o heteroarilo; m es cero o el número entero 1, 2 ó 3; n es cero o el número entero 1, 2 ó 3; en el que la suma de m y n es cero o el número entero 1, 2 ó 3; R1 es un grupo seleccionado de alquilo C1-6, arilo, heteroarilo, heterocicloal- quilo, cicloalquilo C3-6, -alquil C1-6-arilo, -alquil C1-6-heteroarilo, - alquil C1-6-heteroci- cloalquilo o -alquil C1-6-cicloalquilo C3-6, en el que cada grupo arilo o heteroarilo, pre- sente como grupo R1 o como parte del mismo, puede estar sustituido opcionalmente con 1, 2 ó 3 sustituyentes seleccionados del grupo R7, en el que cada R7 puede ser igual o diferente, y es un átomo o grupo seleccionado de F, Cl, Br, alquilo C1-6, haloal- quilo C1-6, alcoxi C1-6, haloalcoxi C1-6, -CN, -CO2R7a, -CON(R7a)2 o -COR7a; y en el que cada grupo alquilo, heterocicloalquilo o cicloalquilo, presente como grupo R1 o como parte del mismo, puede estar sustituido opcionalmente con 1, 2 ó 3 sustituyentes se- leccionados del grupo R8, en el que cada R8 puede ser igual o diferente, y es un átomo o grupo seleccionado de F, alquilo C1-6, haloalquilo C1-6, alcoxi C1-6, haloalcoxi C1-6, =O, =NOR10, -CO2R8a, -CON(R8a)2 o -COR8a; R7a, que pueden ser iguales o diferentes, son cada uno un átomo de hidrógeno, o un grupo alquilo C1-6 o haloalquilo C1-6; R8a, que pueden ser iguales o diferentes, son cada uno un átomo de hidrógeno, o un grupo alquilo C1-6 o haloalquilo C1-6; R10 es un átomo de hidrógeno o un grupo alquilo C1-3; R2 es un átomo de hidrógeno o un grupo alquilo C1-3; o R1 y R2 junto con el átomo de carbono al que están unidos forman un grupo cicloalquilo C3-6 o heterocicloalquilo sustituido opcionalmente con 1, 2 ó 3 sustituyentes seleccionados del grupo R9, en el que cada R9 puede ser igual o diferente, y es un átomo o grupo seleccionado de F, alquilo C1-6, haloalquilo C1-6, alcoxi C1-6, haloalcoxi C1-6, =O, =NOR10, -CO2R8a, -CON(R8a)2 o -COR8a; R3 es un átomo o grupo seleccionado de F, Cl, Br, alquilo C1-3, haloalquilo C1-3, alcoxi C1-3, haloalcoxi C1-3 o -CN; R4 es un átomo de hidrógeno, F, Cl o Br o un grupo alquilo C1-3, haloalquilo C1-3, alcoxi C1-3, haloalcoxi C1-3, -CN, -SO2R5, -SO2N(R6)2, -CON(R6)2, -N(R6)2, -NHSO2R5 o - NHCOR5; R5 es un grupo alquilo C1-3; R6, que pueden ser iguales o diferentes, son cada uno un átomo de hidrógeno o un grupo alquilo C1-3; y Ra y Rb, que pueden ser iguales o diferentes, son cada uno un átomo o grupo seleccionado de hidrógeno o alquilo C1-3, o Ra y Rb pueden estar unidos para formar un grupo cicloalquilo C3-6 o heterocicloalquilo como se definió para R1 y R2; y sus sales, solvatos, hidratos, tautómeros, isómeros o N-óxidos.
-
公开(公告)号:CA2528316A1
公开(公告)日:2004-12-29
申请号:CA2528316
申请日:2004-06-18
Applicant: CELLTECH R&D LTD
Inventor: ALLEN DANIEL REES , SHARPE ANDREW , DYKE HAZEL JOAN , OWEN DAVID ALAN , WATSON ROBERT JOHN
IPC: C07D211/96 , A61K31/451 , A61P37/00
Abstract: A class of piperidine and related heterocyclic derivatives, C-substituted by a substituted aryl or heteroaryl moiety, and N-substituted by an ethylsulfonyl group which in turn is substituted at the 2-position by a hydroxamic acid moiety and also by a range of alternative substituents, being potent inhibitors of CD23 shedding, are useful in the treatment and/or prevention o f allergic, inflammatory and neoplastic diseases.
-
公开(公告)号:AU2004232524A1
公开(公告)日:2004-11-04
申请号:AU2004232524
申请日:2004-04-08
Applicant: CELLTECH R&D LTD
Inventor: WATSON ROBERT JOHN , OWEN DAVID ALAN , MEISSNER JOHANNES WILHELM GEOR
IPC: A61P37/02 , A61P37/08 , C07D211/58 , C07D409/12 , A61K31/452
-
公开(公告)号:CA2528317A1
公开(公告)日:2004-12-29
申请号:CA2528317
申请日:2004-06-18
Applicant: CELLTECH R&D LTD
Inventor: WATSON ROBERT JOHN , SHARPE ANDREW , ALLEN DANIEL REES , OWEN DAVID ALAN , DYKE HAZEL JOAN
IPC: C07D295/22 , A61K31/496 , A61P37/08 , C07D211/56 , C07D295/26 , C07D309/14
Abstract: A class of piperazine and related heterocyclic derivatives, substituted at t he 4-position by a substituted aryl or heteroaryl moiety, and at the 1-position by an ethylsulfonyl group which in turn is substituted at the 2-position by a hydroxamic acid moiety and also by a range of alternative substituents, bein g potent inhibitors of CD23 shedding, are useful in the treatment and/or prevention of allergic, inflammatory and neoplastic diseases.
-
公开(公告)号:AU2003208423A1
公开(公告)日:2003-09-09
申请号:AU2003208423
申请日:2003-02-19
Applicant: CELLTECH R&D LTD
IPC: A61K31/4468 , A61P1/04 , A61P11/06 , A61P17/00 , A61P19/02 , A61P25/00 , A61P27/16 , A61P29/00 , A61P31/12 , A61P33/00 , A61P37/02 , A61P37/06 , C07D211/58 , C07D401/12 , C07D405/12 , C07D409/12 , A61K31/453 , A61K31/4535 , A61K31/4709 , A61K31/17 , C07C275/28
Abstract: Cyclic amino derivatives of formula (1) are described: (1) wherein: m and n, which may be the same or different, is each zero or the integer 1 or 2; Alk 3 is a covalent bond or a straight or branched C 1-6 alkylene chain; R 1 and R 2 , which may be the same or different, is each a hydrogen atom or a straight or branched C 1-6 alkyl group; D is an optionally substituted aromatic or heteroaromatic group; E is an optionally substituted C 7-10 cycloalkyl, C 7-10 cycloalkenyl or C 7-10 polycycloaliphatic group; and the salts, solvates, hydrates, tautomers or N-oxides thereof. The compounds are potent and selective modulators of the interaction between CXCR3 and its chemokine ligands and are thus of use in medicine, for example in the prevention or treatment of conditions involving inappropriate T-cell trafficking such as certain inflammatory, autoimmune and immunoregulatory disorders as described hereinafter.
-
公开(公告)号:DE602004003256D1
公开(公告)日:2006-12-28
申请号:DE602004003256
申请日:2004-06-18
Applicant: CELLTECH R&D LTD
Inventor: OWEN DAVID ALAN , WATSON ROBERT JOHN , ALLEN DANIEL REES , SHARPE ANDREW , DYKE HAZEL JOAN
IPC: C07D211/96 , A61K31/451 , A61P37/00
-
-
-
-
-
-
-
-
-